866-997-4948 (US-Canada Toll Free)

Cancer Symptoms Partnering 2007-2013

Published By :

Current Partnering

Published Date : 2013-10-08

Category :

Biotechnology

No. of Pages : 150

Product Synopsis

The Cancer Symptoms Partnering 2007-2013 report provides understanding and access to the cancer symptoms partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in solid tumor cancer partnering deals Top solid tumor cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type   The Solid Tumor Cancer Partnering 2007-2013 provides understanding and access to the solid tumor cancer partnering deals and agreements entered into by the worlds leading healthcare companies.   This report provides details of thelatest cancer symptoms agreements announced in the healthcare sectors, covering:   Symptoms Oral mucositis Cancer pain... Read More

Table Of Content

TABLE OF CONTENT

Executive Summary
 
Chapter 1 – Introduction
 
Chapter 2 – Trends in cancer symptoms partnering
2.1. Introduction
2.2. Cancer symptoms partnering over the years
2.3. Bigpharma cancer symptoms dealmaking activity
2.4. Cancer symptoms partnering by deal type
2.5. Cancer symptoms partnering industry sector
2.6. Cancer symptoms partnering by stage of development
2.7. Cancer symptoms partnering by technology type
2.8. Disclosed financial deal terms for cancer symptoms partnering
2.8.1 Cancer symptoms headline values
2.8.2 Cancer symptoms upfront payments
2.8.3 Cancer symptoms milestone payments
2.8.4 Cancer symptoms royalty rates
 
Chapter 3 – Leading cancer symptoms deals
3.1. Introduction
3.2. Top cancer symptoms deals by value
3.3. Top cancer symptoms deals involving bigpharma
 
Chapter 4 – Dealmaking directory
4.1. Introduction
4.2. Company A-Z
4.3. By deal type
Asset purchase
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Contract service
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Termination
4.4. By industry sector
Academic
Bigpharma
Biotech
Drug delivery
Medical device
Diagnostic
Generic pharma
Government
Non-profit
Pharmaceutical
Research tools
Services
Specialty pharma
4.5. By stage of development
Discovery
Pre-clinical
Phase I
Phase II
Phase III
Registration
Marketed
4.6. By technology type
Analysis
Animal models
Assays
Bioinformatics
Biological compounds
Biomarkers
Biomaterials
Cell culture
Cell therapy
Clinical testing
Diagnostic - companion
Devices
Diagnostics
Discovery tools
DNA probes
Drug delivery
Enabling technology
Epigenetics
Equipment
Facilities
Gene therapy
Genomics
Imaging
Industrial chemicals
In vitro models
Monoclonal antibodies
Nanotechnology
Oligonucleotide
Peptides
Personalised medicine
Processes
Proteomics
Radio/Chemo-therapy
Recombinant DNA
Research services
Research supplies
RNA therapeutics
Screening
Small molecules
Stem cells
Vaccines
 
Chapter 5 – Partnering resource center
5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking
 
Appendices
 
Appendix 1 – Deal type definitions
 
About Wildwood Ventures
Current Partnering
Current Agreements
Recent titles from CurrentPartnering
Order Form – Reports

List of Tables

NA

List of Figures

 
Figure 1: Cancer symptoms partnering since 2007
Figure 2: Bigpharma – top 50 – Cancer symptoms deals 2007 to 2013
Figure 3: Bigpharma cancer symptoms deal frequency – 2007 to 2013
Figure 4: Cancer symptoms partnering by deal type since 2007
Figure 5: Cancer symptoms partnering by industry sector since 2007
Figure 6: Cancer symptoms partnering by stage of development since 2007
Figure 7: Cancer symptoms partnering by technology type since 2007
Figure 8: Cancer symptoms deals with a headline value
Figure 9: Cancer symptoms deals with upfront payment values
Figure 10: Cancer symptoms deals with milestone payments
Figure 11: Cancer symptoms deals with royalty rates, %
Figure 12: Top cancer symptoms deals by value since 2007
Figure 13: Top cancer symptoms deals signed by bigpharma value since 2007
Figure 14: Online partnering resources
Figure 15: Forthcoming partnering events
Figure 16: Deal type definitions

Make an enquiry before buying this Report

Please fill the enquiry form below.

Full Name * Message
Your Email *
Job Title
Phone No. * (Pls. Affix Country Code) Security Code *

Upcoming Reports

  • Disperse Dyes Market - Global Industry Analysis, Size, Share, Trends and Forecast 2014 - 2020

    By - Transparency

    Disperse dyes are basically water insoluble type of dyes. Disperse dyes are usually finely ground and are made available in the form of paste or a powder. When this paste or powder is dispersed in water, disperse dyes can be used to dye textile fibers. The disperse dyes in the form of particles dissolve in the textile fibers and then impart color to them. These dyes were initially developed for dyeing cellulose acetate, however, nowadays they are also used to dye cellulose triacetate, polyester, nylon and acrylic fibers. The growing demand for disperse dyes in the textile fibers market...

  • Drugs Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

    By - Transparency

    Drug testing business is described as providing of drug testing services to the various private and government agencies. Drugs testing services are primarily required for screening devices, defensive tools and for legal requirement. Drug testing is gaining importance in various parts of the world due to year on year rising instances of drug abuse among employees, students and athletes. Annually, millions of samples are tested for the presence of drug metabolites and alcohol. Moreover, drug testing agencies play an important role in indentifying drug addicts and providing solutions to help...

  • Armored Vehicle Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast 2013 - 2019

    By - Transparency

    The global armored vehicle market is expected to show a remarkable growth rate by coming years. These vehicles help in protecting the personnel inside the vehicle from enemy fire. These vehicles are made up from various materials include metals, plastic, ceramic, glass, and composite. Armored vehicles are mainly used and are expected to remain a very important part in military operations. These vehicles provide ground forces with enhanced capabilities in terms of mobility, firepower and protection. One of the major factors contributing the growth of the global armored vehicle market is the...